BHU scientists secure patent for Ayurvedic formulation inhibiting over 95% Covid virus growth

NEW DELHI: Researchers from the centre for genetic orders at Banaras Hindu University (BHU) have achieved a major milestone in the fight against the SARS-CoV-2 virus, securing an Indian patent for an innovative Ayurvedic formulation that combines the phytomolecules of Ashwagandha (Withania somnifera) and Morus alba. This formulation has demonstrated over 95% effectiveness in inhibiting viral growth in cell lines, marking it as a promising candidate for future COVID-19 treatments.

In addition to the Indian patent, the team has filed two international patents and received two German patents for related research. Their relentless efforts, which began in the early days of the pandemic, highlight a promising pathway for inhibiting the growth of SARS-CoV-2, BHU said.

Drawing on the therapeutic properties of these traditional Ayurvedic ingredients, the formulation has shown considerable efficacy in preliminary studies. The next steps will involve testing in animal models, followed by clinical trials to evaluate its effects in humans.

BHU patent

The patent recognizes the efforts of a distinguished team led by professor Parimal Das, alongside PhD scholars Prashant Ranjan, Neha, Chandra Devi, and Prashasti Yadav, as well as Dr Garima Jain (Malaviya Post Doctoral Fellow), Dr Chandana Basu Malick (Wellcome Trust Fellow), and Dr Bhagyalaxmi Mohapatra (department of zoology). This collaborative achievement underscores the potential of Ayurvedic phytomolecules in modern medical research.

Also read 4 private universities ahead of all IITs together in patent applications

Professor Das expressed optimism about the formulation, stating, “This achievement reflects the dedication and hard work of our team. We are hopeful that it can provide a natural solution to combat SARS-CoV-2.”

This groundbreaking discovery, rooted in Ayurvedic science, offers renewed hope in the ongoing global battle against the pandemic and showcases the commitment of young researchers dedicated to this critical project, added the university.